Atlas Trials

Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease

Clinical trial NCT06754891 · RECRUITING

Trial details

NCT number
NCT06754891
Sponsor
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Inflammatory Bowel Diseases
Start date
2025-01-28
Primary completion
2027-07-01
Enrollment
135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.